Oct 2026· Frontiers in Genetics· Vol 17· 0 citations· 9 references
TL;DR
Two adult sisters with genetically confirmed HAYOS who exhibited early-onset hypotonia progressing to spasticity, craniofacial dysmorphism, optic atrophy, and sensorimotor polyneuropathy are reported, demonstrating that severe progressive motor disability may coexist with relative cognitive preservation at adult assessment, limited cardiac or metabolic involvement, and long-term survival.
Abstract
Harel–Yoon syndrome (HAYOS) is a rare neurometabolic disorder caused by pathogenic variants in the
ATAD3A
gene, a key regulator of mitochondrial dynamics and cellular homeostasis. Although a broad phenotypic spectrum has been described, the relationship between genotype and long-term functional outcomes remains incompletely understood.
We report two adult sisters with genetically confirmed HAYOS who exhibited early-onset hypotonia progressing to spasticity, craniofacial dysmorphism, optic atrophy, and sensorimotor polyneuropathy. Neuroimaging revealed mild cerebellar atrophy, and electrophysiological studies showed a chronic sensorimotor polyneuropathy with axonal loss and conduction slowing. Initial exome sequencing revealed a variant of uncertain significance in
COL5A1
, whereas subsequent targeted familial Sanger sequencing confirmed the heterozygous
ATAD3A
NM_001170535.3:c.1582C>T (p.Arg528Trp) variant in both sisters. Parental segregation could not be assessed because their father died before genetic evaluation and their mother declined further clinical evaluation and targeted segregation testing for the familial
ATAD3A
variant. Despite severe progressive motor impairment leading to wheelchair dependence, both patients completed formal education and had low-average IQ scores (88 and 82) at single adult assessments.
These cases expand the phenotypic spectrum of HAYOS by demonstrating that severe progressive motor disability may coexist with relative cognitive preservation at adult assessment, limited cardiac or metabolic involvement, and long-term survival. Our findings highlight the diagnostic challenges posed by the ATAD3 locus and underscore the importance of comprehensive genetic evaluation in suspected mitochondrial disorders. Rather than representing a globally mild phenotype, these patients show a motor-severe but cognitively and systemically attenuated presentation, with implications for prognosis, genetic counseling, and clinical management.
It is suggested that ATP1A3 should be considered in the genetic evaluation of unexplained adult-onset upper motor neuron syndromes and represents the first reported adult-onset primary lateral sclerosis-like phenotype associated with an ATP1A3 variant.
Pablo Hernández-Vitorique, Marta García de Burgos, Ana Campos Villegas et al.· Clinical Genetics· 0 citations
Harel-Yoon syndrome is a rare mitochondrial disorder caused by pathogenic variants in ATAD3A, typically characterized by neonatal respiratory insufficiency, cataracts, developmental delay, hypotonia, and cerebellar atrophy. We report a pediatric patient with compound heterozygous missense variants in ATAD3A (c.655C>T,...
Ting-Ting Wen, Hong-Yu Chen, Lan Yu et al.· American Journal of Medical...· 0 citations
Background: BRAT1-related disorders constitute a continuous neurodevelopmental spectrum ranging from rigidity and multifocal seizure syndrome, lethal neonatal form (RMFSL) to milder phenotypes characterized by cerebellar involvement and variable developmental impairment. Genotype–phenotype correlations remain incomplet...
Camilla Meossi, L. Cipriano, Flavio Dal Canto et al.· Medical Science· 0 citations
Wieacker–Wolff syndrome (WWS), also termed ZC4H2-associated rare disorder (ZARD), is a rare X-linked neurodevelopmental disorder caused by pathogenic variants in ZC4H2 at chromosome Xq11.2. Core manifestations include developmental delay, hypotonia, intellectual disability, distal muscle weakness and congenital contrac...
Neetu Garg, Shobit Garg· Journal of Rare Diseases· 0 citations
Findings support a role for GABBR2‐mediated GABAergic signaling in the pathophysiology of RTT and highlight the importance of considering GABBR2 in the genetic evaluation of MECP2‐negative patients with a clinical RTT phenotype.
Jenny Klintenstedt, P. Baeck, I. Engerström et al.· Molecular Genetics & Genomic...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.